Prosecution Insights
Last updated: October 01, 2026

Examiner: RODRIGUEZ-GARCIA, VALERIE

Tech Center 1700 • Art Units: 1600 1621 1622 1626 1759

This examiner grants 69% of resolved cases

Analysis

Valerie Rodriguez-Garcia is an examiner in Tech Center 1700, Art Unit 1600. She has handled 832 resolved cases, maintaining an allowance rate of 68.9 percent. This rate provides a positive outlook for applicants, suggesting that a majority of the applications reaching a resolution are granted. Practitioners can use this 68.9 percent figure to set realistic expectations for the outcome of their patent filings in this tech center.

The interview lift for this examiner is 31.8 percent. This is a significant lift, indicating that interviews are very effective at moving cases toward allowance. The 31.8 percent increase suggests that direct engagement with the examiner is an impactful step a practitioner can take. Given the 832 resolved cases, this lift is a statistically reliable indicator that interviews should be considered a key part of the prosecution strategy.

The median days to allowance is 901. This timeframe offers a benchmark for the speed of the examination process from filing to grant. For those in Art Unit 1600, the 901 days represent a standard duration for successful prosecution. Managing a docket of 832 cases while maintaining this median timeline provides a clear picture of the examiner's typical workflow and efficiency.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

68.9%
Allow Rate
+3.9% vs TC avg
865
Total Applications
+31.8%
Interview Lift
901
Avg Prosecution Days
Based on 832 resolved cases, 2023–2026

Rejection Statute Breakdown

3.0%
§101 Eligibility
22.5%
§102 Novelty
22.5%
§103 Obviousness
38.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18661776 SKIN CARE COMPOSITION COMPRISING HYDROXYCINNAMIC ACID AND NIACINAMIDE DERIVATIVE Non-Final OA The Procter & Gamble Company
18019501 USE OF STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI CONTAINING AN AMINO ACID SUBSTITUTION F129L IN THE MITOCHONDRIAL CYTOCHROME B PROTEIN CONFERRING RESISTANCE TO QO INHIBITORS VIII Non-Final OA BASF SE
17997872 FUNGICIDAL COMPOSITIONS Final Rejection SYNGENTA CROP PROTECTION AG
18272221 GLYCIDYL (METH)ACRYLATE COMPOSITION Final Rejection MITSUBISHI GAS CHEMICAL COMPANY, INC.
16807102 METHODS FOR TREATING PROTEINOPATHIES Non-Final OA Genzyme Corporation
18579733 AAK1 INHIBITOR AND USE THEREOF Non-Final OA Xizang Haisco Pharmaceutical Co., Ltd.
17771732 NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES Non-Final OA Elanco Animal Health GmbH

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month